Anterogen.Co.Ltd (065660) — Capital Reinvestment Ratio

Latest as of September 2025: 0.10x

Anterogen.Co.Ltd (065660) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩281.98 Million) in capital expenditures (₩27.45 Million). See debt-free asset ratio of Anterogen.Co.Ltd to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.10x
Capex / Operating Cash Flow

Operating Cash Flow

₩281.98 Million
KRW

Capital Expenditures

₩27.45 Million
KRW

Data as of

Sep 2025
Most recent filing

Anterogen.Co.Ltd Capital Reinvestment Ratio (2015–2017)

This chart tracks Anterogen.Co.Ltd's Capital Reinvestment Ratio across 2 annual periods. Check 065660 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Anterogen.Co.Ltd (2015–2017)

Year-by-year Capital Reinvestment Ratio for Anterogen.Co.Ltd from 2015 to 2017. For live market cap and broader valuation context, see 065660 market cap.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2017 1.68x ₩379.21 Million ₩637.46 Million ▲ +115.4%
2015 0.78x ₩844.49 Million ₩659.00 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow